Michael Leshchinsky

Michael Leshchinsky

Auto-generated profile, based on publicly available information

Michael Leshchinsky

Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2024 in NEJM AI
Verified
Journal Article
Closed access
NDNoa Dagan
Noa Dagan
OMOri Magen
Ori Magen
MLMichael Leshchinsky
Michael Leshchinsky
MMMaya Makov-Assif
Maya Makov-Assif
MLMarc Lipsitch
Marc Lipsitch
RBRan D. Balicer
Ran D. Balicer

15 November 2022 in Blood
Verified
Journal Article
Open access
Moshe MittelmanMoshe Mittelman
Moshe Mittelman
HOHoward S. Oster
Howard S. Oster
YSYatir Ben Shlomo
Yatir Ben Shlomo
AIAriel Israel
Ariel Israel
ODOsnat Jarchowcky Dolberg
Osnat Jarchowcky Dolberg
GSGalit Shaham
Galit Shaham
Background: Multiple myeloma (MM) evolves over years. Pre-MM states, such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM, are as